跳至主要内容
临床试验/ISRCTN12622749
ISRCTN12622749已完成未知

A prospective, multi-center, randomized, double blinded, placebo-controlled study for the evaluation of iloprost in the early postoperative period after liver transplantation

Friedrich-Schiller-University Jena (Germany)0 个研究点目标入组 356 人开始时间: 2012年10月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
356

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Current inclusion criteria as of 07/03/2013:
  • 1. Full-size liver transplantation
  • 2. Informed consent of the patient or legal representative
  • 3. Aged 18 years or over
  • Previous inclusion criteria:
  • 1. Full-size liver transplantation
  • 2. Informed consent of the patient or legal representative
  • 3. Age over 18 years

排除标准

  • 1. Women of child-bearing potential except women with the following criteria:
  • 1.1. Post menopausal (12 months natural amenorrhea or 6 month amenorrhea with serum FSH > 40 mlU/ml)
  • 1.2. Sterilization 86 weeks after bilateral ovarectomy with or without hysterectomy
  • 1.3. Using an effective method of birth control for the duration of trial:
  • 1.3.1 Implants, injectables, combined oral contraceptives, intra-uterine device (in place for a period of at least 2 months prior to screening) and with negative serum pregnancy test
  • 1.4. Sexual abstinence
  • 2. Pregnancy/lactation
  • 3. Respiratory and/or circulatory instability (noradrenaline > 1 pg/kgBWmin and FiOz > 0.6) after liver transplantation (LT) before randomization
  • 4. Split liver transplantation/living donor related liver transplantation
  • 5. Retransplantation
  • 6. Receiving a multi-organ transplantation
  • 7. Participation on other clinical trials 30 days prior to randomization
  • 8. Known allergic reaction against trial medication
  • 9. Conditions in which bleeding complications may be expected from the effect of lloprost on platelets
  • 10. Severe coronary artery disease or unstable angina pectoris
  • 11. Myocardial infarction within the past 6 months prior to baseline assessment after acceptance of donor organ
  • 12. Acute or chronic heart failure (NYHA ll-lV)
  • 13. Cardiac arrhythmias relevant for the prognosis
  • 14. Suspected pulmonary artery congestion
  • 15. Known allergy or intolerance against tacrolimus, mycophenolate mofetil, basiliximab or corticosteroids

研究者

发起方
Friedrich-Schiller-University Jena (Germany)

相似试验

进行中(未招募)
1 期
A prospective, multi-center, randomized, double blinded, placebo-controlled study for the evaluation of Iloprost in the early postoperative period after liver transplantatio
EUCTR2010-022660-12-DEFriedrich Schiller University430
进行中(未招募)
3 期
A prospective, multi-center, randomized, double blinded, placebo-controlled study for the evaluation of Iloprost in the early postoperative period after liver transplantatioK74.6K72.0T86.40T86.41Other and unspecified cirrhosis of liverAcute and subacute hepatic failure
DRKS00003514Friedrich Schiller Universität Jena -Universitätsklinikum Jena37
进行中(未招募)
不适用
A prospective, multi-center, randomized, double-blind trial to assess theeffectiveness and safety of 12 versus 30 months of dual antiplatelet therapy(DAPT) in subjects undergoing percutaneous coronary intervention (PCI) witheither drug-eluting stent (DES) or bare metal stent (BMS) placement for thetreatment of coronary artery lesions. - DAPT StudyDual antiplatelet therapy (DAPT) in subjects undergoing percutaneous coronary intervention (PCI) with either drug eluting stent (DES) or bara metal stent (BMS) placement for the treatment of coronary artery lesions.MedDRA version: 12.1Level: LLTClassification code 10051592Term: Acute coronary syndrome
EUCTR2009-015712-17-HUHCRI20,645
进行中(未招募)
不适用
A prospective, multi-center, randomized, double-blind trial to assess theeffectiveness and safety of 12 versus 30 months of dual antiplatelet therapy(DAPT) in subjects undergoing percutaneous coronary intervention (PCI) witheither drug-eluting stent (DES) or bare metal stent (BMS) placement for thetreatment of coronary artery lesions. - DAPT Study
EUCTR2009-015712-17-GBHCRI20,645
尚未招募
不适用
A prospective, multi-center, randomized, double-blind placebo parallel controlled clinical trial study of Qin's Xiaobi Gel Plaster in the treatment of knee osteoarthritisKnee osteoarthritis
ITMCTR2100005256Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
Evaluation of iloprost in the postoperative period... | 临床试验